UPL.NS

UPL Limited [UPL.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

UPL.NS Stock Summary

Earnings have grown 20.36% per last year.

Earnings are expected to rise 13.83% next year

EPS has been increasing for the past 3 years (Yearly statements)

EPS has been increasing for the past 3 quarters (Quarter statements)

UPL.NS's dividend payments are well covered by cash flows with cash payout ratio of 18.06%.

UPL.NS has less than 1 year of cash runway

Top 10 Correlated ETFs

UPL.NS

Top 10 Correlated Stocks

UPL.NS

In the News

UPL.NS Financial details

Company Rating

Strong Buy

Market Cap

538.67B

Income

41.57B

Revenue

528.68B

Book val./share

Cash/share

Dividend

Dividend %

1.39%

Employees

13.05K

Optionable

Shortable

Yes

Earnings

08 May 2023

P/E

13.88

Forward P/E

10.25

PEG

3.24

P/S

1.09

P/B

2.31

P/C

P/FCF

Quick Ratio

0.17

Current Ratio

1.36

Debt / Equity

LT Debt / Equity

0.96

EPS (TTM)

51.99

EPS next Y

69.37

EPS next Q

EPS this Y

30.38%

EPS next Y

33.43%

EPS next 5Y

62.13%

EPS last 5Y

12.34%

Revenue last 5Y

21.92%

Revenue Q/Q

9.37%

EPS Q/Q

24.84%

SMA20

-2.69%

SMA50

-1.91%

SMA100

-2.73%

Inst Own

Inst Trans

ROA

ROE

17%

ROC

0.16%

Gross Margin

53%

Oper. Margin

18%

Profit Margin

Payout

Shs Outstand

750.61M

Shs Float

560.84M

Target Price

52W Range

607.5-848.0

52W High

-16.11%

52W Low

+17.19%

RSI

48.87

Rel Volume

0.07

Avg Volume

1.88M

Volume

134.33K

Perf Week

0.45%

Perf Month

-7.54%

Perf Quarter

3.03%

Perf Half Y

7.18%

Beta

0.995215

Volatility

6.57%, 20.83%

Prev Close

0.56%

Price

711.34998

Change

-0.45%

UPL.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-03-31

Metric	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31
Revenue per share	225.14	285.81	465.96	502.82	605.2
Net income per share	26.52	18.94	23.25	37.58	47.46
Operating cash flow per share	37.24	30.84	114.38	94.39	85.02
Free cash flow per share	18.71	10.22	88.47	66.62	49.84
Cash per share	38.09	38.81	88.9	63.7	108.34
Book value per share	120.28	191.69	252.37	273.36	322.77
Tangible book value per share	97.02	-129.07	-98.2	-55.73	-1.62
Share holders equity per share	120.28	191.69	252.37	273.36	322.77
Interest debt per share	94.8	393.12	404.78	339.86	375.04
Market cap	382.37B	475.88B	249.46B	490.4B	588.01B
Enterprise value	420.16B	739B	476.08B	686.49B	797.13B
P/E ratio	18.91	32.89	14.05	17.08	16.22
Price to sales ratio	2.23	2.18	0.7	1.28	1.27
POCF ratio	13.47	20.2	2.85	6.8	9.05
PFCF ratio	26.81	60.93	3.69	9.63	15.44
P/B Ratio	4.17	3.25	1.29	2.35	2.38
PTB ratio	4.17	3.25	1.29	2.35	2.38
EV to sales	2.45	3.38	1.34	1.79	1.72
Enterprise value over EBITDA	11.8	21.25	8.05	9.42	9.42
EV to operating cash flow	14.8	31.37	5.45	9.52	12.27
EV to free cash flow	29.46	94.62	7.04	13.49	20.93
Earnings yield	0.05	0.03	0.07	0.06	0.06
Free cash flow yield	0.04	0.02	0.27	0.1	0.06
Debt to equity	1.51	3.08	2.46	2.2	2.16
Debt to assets	0.6	0.71	0.68	0.65	0.65
Net debt to EBITDA	1.06	7.57	3.83	2.69	2.47
Current ratio	1.97	1.73	1.75	1.53	1.41
Interest coverage	4.87	3.51	3.35	4.15	4
Income quality	1.4	1.63	4.92	2.51	1.79
Dividend Yield	0.01	0.01	0.02	0.01	0.01
Payout ratio	0.18	0.28	0.23	0.16	0.21
Sales general and administrative to revenue	0.02	0.02	0.02	0.02	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.08	0.44	0.43	0.41	0.36
Capex to operating cash flow	-0.5	-0.67	-0.23	-0.29	-0.41
Capex to revenue	-0.08	-0.07	-0.06	-0.06	-0.06
Capex to depreciation	-2.09	-1.63	-0.98	-0.98	-1.14
Stock based compensation to revenue	0	0	0	0	0
Graham number	267.92	285.8	363.31	480.75	587.07
ROIC	0.22	0.06	0.09	0.11	0.13
Return on tangible assets	0.1	0.04	0.04	0.07	0.07
Graham Net	-113.89	-490.12	-481.29	-474.76	-504.6
Working capital	73.89B	114.27B	125.56B	104.43B	115.32B
Tangible asset value	73.96B	-98.61B	-75.03B	-42.58B	-1.24B
Net current asset value	11.76B	-180.54B	-182.47B	-157.82B	-136.43B
Invested capital	0.72	1.99	1.52	1.17	1.08
Average receivables	0	0	0	0	0
Average payables	52.75B	75.49B	98.28B	113.79B	145.39B
Average inventory	43.47B	69.04B	85.6B	86.36B	112.5B
Days sales outstanding	0	0	0	0	0
Days payables outstanding	251.44	310.08	196.49	235.25	273.72
Days of inventory on hand	201.06	305.01	150.73	176.97	216.27
Receivables turnover	0	0	0	0	0
Payables turnover	1.45	1.18	1.86	1.55	1.33
Inventory turnover	1.82	1.2	2.42	2.06	1.69
ROE	0.22	0.1	0.09	0.14	0.15
Capex per share	-18.54	-20.61	-25.92	-27.77	-35.18

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q3

Metric	2021-12-31	2022-03-31	2022-06-30	2022-09-30	2022-12-31
Revenue per share	138.32	194.2	132.76	166.4	170.14
Net income per share	11.46	16.88	10.76	10.83	13.52
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	101.35	0	75.24	0
Book value per share	0	301.94	0	332.06	0
Tangible book value per share	0	-1.52	0	-11.88	0
Share holders equity per share	0	301.94	0	332.06	0
Interest debt per share	0	334.7	0	453.45	0
Market cap	610.2B	628.57B	515.44B	505.12B	575.78B
Enterprise value	0	837.69B	0	803.62B	0
P/E ratio	16.3	11.4	14.69	15.51	13.24
Price to sales ratio	5.4	3.96	4.76	4.04	4.21
POCF ratio	0	0	0	0	0
PFCF ratio	0	0	0	0	0
P/B Ratio	0	2.55	0	2.02	0
PTB ratio	0	2.55	0	2.02	0
EV to sales	0	5.28	0	6.43	0
Enterprise value over EBITDA	0	28.75	0	34.99	0
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	0.02	0.02	0.02	0.02	0.02
Free cash flow yield	0	0	0	0	0
Debt to equity	0	2.16	0	2.4	0
Debt to assets	0	0.65	0	0.67	0
Net debt to EBITDA	0	7.18	0	13	0
Current ratio	0	1.41	0	1.36	0
Interest coverage	3.92	4.68	4.15	3.43	2.7
Income quality	0	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0	0.36	0	0.34	0
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0	338.68	0	284.45	0
ROIC	0	0.05	0	0.03	0
Return on tangible assets	0	0.03	0	0.01	0
Graham Net	0	-472.04	0	-590.93	0
Working capital	0	115.32B	0	118.03B	0
Tangible asset value	0	-1.24B	0	-8.93B	0
Net current asset value	0	-136.43B	0	-152.79B	0
Invested capital	0	1.08	0	1.34	0
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	186.35	0	303.99	0
Days of inventory on hand	0	147.24	0	302.91	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0.48	0	0.3	0
Inventory turnover	0	0.61	0	0.3	0
ROE	0	0.06	0	0.03	0
Capex per share	0	0	0	0	0

UPL.NS Dividend History

UPL.NS Frequently Asked Questions

What is UPL Limited stock symbol ?

UPL Limited is a IN stock and trading under the symbol UPL.NS

What is UPL Limited stock quote today ?

UPL Limited stock price is $711.34998 today.

Is UPL Limited stock public?

Yes, UPL Limited is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.88M
Market Capitalization 538.67B
Employee 13.05K
CEO Mr. Jaidev Rajnikant Shroff B.Sc.
Headquarters Mumbai,IN
IPO Date 1996-02-26
Website https://www.upl-ltd.com

UPL Limited engages in the provision of sustainable agriculture products and solutions in India and internationally. It operates through two segments, Agro Activity and Non-Agro Activity. The company offers sorghum, forages, corn, canola, sunflower, vegetable, rice, wheat, soya, pearl millet, oats, alfalfa, bio-fumigants, and mustard seeds. It also provides herbicides; fungicides; insecticides and acaricides; seed treatment products; adjuvants; and ProNutiva, a solution for crop protection. In addition, the company offers plant stress and stimulation solutions; post-harvest products including coatings, cleaners, sanitisers, fungicides, growth regulators, and anti-scald; soil and water technologies; aquatic treatment solutions; and farmer advisory and education services, as well as farm services. Further, it produces and sells industrial chemicals, chemical intermediates, speciality chemicals and non agricultural related products. UPL Limited has a strategic collaboration with Chr. Hansen Holding A/S to develop microbial-based biosolutions. The company was formerly known as United Phosphorus Limited and changed its name to UPL Limited in October 2013. UPL Limited was founded in 1969 and is headquartered in Mumbai, India.